This paper presents a facile one-pot method to synthesize monodisperse lauric-acid-capped cobalt ferrite nanoparticles (CoFe 2 O 4 NPs)and investigates their potential application as drug carriers for loading and controlled release of doxorubicin (DOX). The lauric-acid-capped CoFe 2 O 4 NPs with a particle size of 15.3 ± 1.7 nm were synthesized via one-pot reaction. Water-soluble lauric-acid-capped CoFe 2 O 4 NPs were obtained through surface modification with cetyltrimethylammonium bromide (CTAB) and sodium dodecyl sulfate (SDS). Furthermore, the performance of water-soluble lauric-acid-capped CoFe 2 O 4 NPs for drug delivery was investigated with DOX hydrochloride. The DOX release percentages of CTAB and SDS modified lauric-acid-capped CoFe 2 O 4 NPs are 56.1% and 48.2%, respectively. These results indicated that the modified lauric-acid-capped CoFe 2 O 4 NPs could be utilized as a promising candidate for cancer chemotherapy by making use of their pH-sensitive drug-release properties.
Raquel Serrano‐GarcíaFinn Purcell‐MiltonSarah A. McCarthyYurii K. Gun’ko
Mukta V. LimayeShashi B. SinghSadgopal K. DateDeepti KothariV. Raghavendra ReddyAjay GuptaVasant SatheRam Jane ChoudharySulabha K. Kulkarni
Véronica Gavrilov-IsaacSophie NeveuVincent DupuisDario TavernaAlexandre GloterValérie Cabuil
Kęstutis MažeikaV. BėčytėYulia Tykhonenko-PolishchukM. M. KulykO.V. YelenichA. I. Tovstolytkin
Carla CannasA. MusinuAndrea ArduFederica OrrùDavide PeddisMariano CasuRoberta SannaFabrizio AngiusGiacomo DiazG. Piccaluga